AgomAb Therapeutics jobs and careers
Ghent, Flanders, Belgium
About AgomAb Therapeutics
AgomAb is pioneering therapies that modulate regenerative pathways to achieve structural tissue repair and functional organ recovery.
Founded in 2017 by Federica Linty, Hans De Haard, Manuela Cazzanti, Michael Saunders and Virginia Morello.
- Founded
- 2017
- Employees
- 11 to 50
- Total funding
- $237M
- Headquarters
- Ghent
Leadership
The top of AgomAb Therapeutics's org chart, with how many people report into each leader.
Tim Knotnerus
CEO
38 reports
Paul van der Horst
Chief Business Officer
8 reports
Tim Van Kaem
Senior VP, Head Clinical Development
7 reports
Torsten Dreier
Chief Development Officer
5 reports
Philippe Wiesel
Chief Medical Officer
4 reports
Ellen Lefever
General Counsel
3 reports
Henk De Jonghe
Head Of Information Technology
1 report
Andrea Sáez Borderías
Chief Development Officer
Melissa Gannon Tokosh
Senior Vice President, Regulatory Affairs
Board
Mike Lee
Director
Ohad Hammer
Director
